Description
Itovebi (inavolisib) is a PI3K alpha-selective inhibitor for PIK3CA-mutated hormone receptor-positive breast cancer.
$12,352.50
PI3K inhibitor for breast cancer
Itovebi (inavolisib) is a PI3K alpha-selective inhibitor for PIK3CA-mutated hormone receptor-positive breast cancer.
Reviews
There are no reviews yet.